ATANIS Biotech AG
PrivateLast Round
Grant
Feb 20, 2025
Total Funding Raised
$2M
Company Overview
ATANIS Biotech AG is a biotechnology company that develops a novel, cell-based allergy diagnostic assay called FAST-PASE® to safely and accurately assess allergic reactions in a test tube.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ATANIS Biotech AG Comparables
Compare ATANIS Biotech AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AllerGenis | 77% | |
| Eurofins Scientific SE | 72% | |
| BÜHLMANN Laboratories AG | 71% |
ATANIS Biotech AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2025 | ||||
| Early Funding | Oct 22, 2024 | ||||
| Early Funding | Mar 28, 2023 |
Key People
Founding team and executive leadership
ATANIS Biotech AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AllerFund | Early Funding |
| Spectrum Moonshot Fund | Early Funding |
| iXLife Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Grew 27% QoQ, from 22 to 28 employees.
- May 1, 2025
Grew 21% QoQ, from 19 to 23 employees.
ATANIS Biotech AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ATANIS Biotech AG's valuation, stock price, and market status.
Is ATANIS Biotech AG a public or private company?
ATANIS Biotech AG is a private company.
What is the current stock price of ATANIS Biotech AG?
ATANIS Biotech AG is a private company with no public stock price. No recent secondary market data is available.
How much is ATANIS Biotech AG worth (valuation)?
Valuation information for ATANIS Biotech AG is not publicly available.
Can I buy ATANIS Biotech AG stock?
ATANIS Biotech AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ATANIS Biotech AG's last funding round?
ATANIS Biotech AG's most recent funding round was Grant on February 20, 2025.
Who are the main investors in ATANIS Biotech AG?
Key investors in ATANIS Biotech AG include AllerFund, Spectrum Moonshot Fund.
Will ATANIS Biotech AG IPO soon?
No public IPO plans have been announced for ATANIS Biotech AG.
How can I track ATANIS Biotech AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ATANIS Biotech AG's secondary market activity and sign up for updates.